Early Time Course of Symptom Improvement With Remibrutinib in Chronic Spontaneous Urticaria: Pooled Post Hoc Analyses of the REMIX-1/2 Phase 3 Studies

Fecha de publicación: --
Fuente: PubMed "hive"
Clin Exp Allergy. 2026 Oct 18. doi: 10.1111/cea.70450. Online ahead of print.NO ABSTRACTPMID:42893886 | DOI:10.1111/cea.70450
Volver